Literature DB >> 7451956

Prevalence of toxoplasma antibodies according to age with comments on the risk of prenatal infection.

J van der Veen, M F Polak.   

Abstract

Sera from 1661 persons in 12 age groups from 0 to 79 years were titrated for toxoplasma antibodies in the indirect immunofluorescence test. The sera were collected from patients with symptoms suggestive of acute, mainly respiratory, viral infections. After the first year of life, the prevalence of antibodies started to rise, reaching 59% between 40 and 79 years of age. From the prevalence of antibodies in different age groups the annual infection risk, i.e, the risk of a non-immune person acquiring toxoplasma infection, was estimated for successive age periods. The estimated annual infection risk increased from 0 . 5% in early childhood to 3% during adolescence and early adult life. Approximately 70--80% of females entered the age of reproduction without evidence of seroimmunity to toxoplasma. The risk of primary infection during pregnancy was estimated from the age distribution of parturient women in The Netherlands in 1975 and the age-specific incidence of primary infections, i.e. the incidence in the total population of susceptible and immune persons. This incidence of primary infection decreased from 1 . 62% per 9 months at the age of 17 1/2--20 years to 0 . 37% at the age of 37--45 years. The incidence of primary infections in pregnant women was estimated to be 1 . 25%.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7451956      PMCID: PMC2133925          DOI: 10.1017/s0022172400063191

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  4 in total

1.  Serological survey of toxoplasmosis in the northern part of Iran, using indirect fluorescent antibody technique.

Authors:  M Ghorbani; G H Edrissian; N Assad
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

2.  Congenital toxoplasmosis. A prospective study of 378 pregnancies.

Authors:  G Desmonts; J Couvreur
Journal:  N Engl J Med       Date:  1974-05-16       Impact factor: 91.245

3.  Examination for toxoplasmosis by the fluorescent antibody technique.

Authors:  M C van Nunen; J van der Veen
Journal:  Trop Geogr Med       Date:  1965-09

4.  [Epidemiological study on toxoplasmosis: the influence of cooking slaughter-animal meat on the incidence of human infection].

Authors:  G Desmonts; J Couvreur; F Alison; J Baudelot; J Gerbeaux; M Lelong
Journal:  Rev Fr Etud Clin Biol       Date:  1965-11
  4 in total
  12 in total

1.  The seroepidemiology of toxoplasmosis in the lower Fraser Valley of British Columbia.

Authors:  E M Proctor; S N Banerjee
Journal:  Can J Infect Dis       Date:  1994-09

Review 2.  Fuchs' heterochromic cyclitis: review of the literature on the pathogenetic mechanisms.

Authors:  E La Hey; P T de Jong; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1994-04       Impact factor: 4.638

Review 3.  Ocular involvement in toxoplasmosis.

Authors:  A Rothova
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

4.  Enzyme-linked immunosorbent assay that uses labeled antigen for detection of immunoglobulin M and A antibodies in toxoplasmosis: comparison with indirect immunofluorescence and double-sandwich enzyme-linked immunosorbent assay.

Authors:  A M van Loon; J T van der Logt; F W Heessen; J van der Veen
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

5.  Congenital ocular toxoplasmosis.

Authors:  D D Perry; J C Merritt
Journal:  J Natl Med Assoc       Date:  1983-02       Impact factor: 1.798

6.  Serology in ocular toxoplasmosis.

Authors:  A Rothova; F van Knapen; G S Baarsma; P J Kruit; D H Loewer-Sieger; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1986-08       Impact factor: 4.638

7.  The prevalence of Toxoplasma antibody in patients with various ocular diseases in central Japan.

Authors:  K Goto; M Kurita; N Masuhara; Y Iijima; K Saeki; S Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

8.  Incidence of congenital toxoplasmosis in live Guatemalan newborns.

Authors:  J Sinibaldi; I De Ramirez
Journal:  Eur J Epidemiol       Date:  1992-07       Impact factor: 8.082

9.  Modified latex agglutination test for antibodies to Toxoplasma gondii in eluates from Guthrie cards.

Authors:  S P Parker; W D Cubitt
Journal:  J Clin Pathol       Date:  1992-10       Impact factor: 3.411

10.  Prevention of congenital toxoplasmosis; experience in The Netherlands.

Authors:  M A Conyn-van Spaendonck
Journal:  Int Ophthalmol       Date:  1989-12       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.